Press release
Celsion Corporation (NASDAQ: CLSN) Long Term Investor Notice: Investigation of potential Wrongdoing
An investigation on behalf of current long term investors in Celsion Corporation (NASDAQ: CLSN) shares.
Investors who are current long term investors in Celsion Corporation (NASDAQ: CLSN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in NASDAQ: CLSN stocks follows a lawsuit filed against Celsion Corporation over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: CLSN stocks, concerns whether certain Celsion directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges thatthe Defendants made false and/or misleading statements and/or failed to disclose that Defendants had significantly overstated the efficacy of ThermoDox, that the foregoing significantly diminished the approval and commercialization prospects for ThermoDox, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Celsion Corporation (NASDAQ: CLSN) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Celsion Corporation (NASDAQ: CLSN) Long Term Investor Notice: Investigation of potential Wrongdoing here
News-ID: 2241715 • Views: …
More Releases from Shareholders Foundation
Ardent Health, Inc. (NYSE: ARDT) Investor Alert: Deadline in Lawsuit on March 09 …
A deadline is coming up on March 09, 2026 in the lawsuit filed for certain investors of Ardent Health, Inc. (NYSE: ARDT) over alleged securities laws violations by Ardent Health, Inc.
Investors who purchased shares of Ardent Health, Inc. (NYSE: ARDT) have certain options and there are strict and short deadlines running. Deadline: March 09, 2026. Ardent Health, Inc. (NYSE: ARDT) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
Sina Corporation (formerly NASDAQ: SINA) Investor Alert: Investigation of potent …
An investigation on behalf of investors in shares of Sina Corporation (formerly NASDAQ: SINA) concerning potential breaches of fiduciary duties by certain directors and officers was announced.
Investors who are current long term investors inSina Corporation (formerly NASDAQ: SINA shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in Sina Corporation (formerly NASDAQ:…
Lawsuit DEADLINE Alert: Investors who lost money with Stride, Inc. (NYSE: LRN) s …
An investor, who purchased shares of Stride, Inc. (NYSE: LRN), filed a lawsuit over alleged violations of Federal Securities Laws by Stride, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Stride, Inc. (NYSE: LRN) have certain options and for certain investors are short and strict deadlines running. Deadline: January 12, 2026. NYSE: LRN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
More Releases for Celsion
Hyperthermia Treatment for Cancer Market Is Going to Boom |• Celsion Corporati …
Worldwide Market Reports has recently released a comprehensive research study titled "Hyperthermia Treatment for Cancer Market Size and Forecast 2026-2033: Breakdown by Manufacturers, Key Regions, Types, and Applications." The report has been developed using a combination of primary and secondary research methodologies, ensuring a detailed and accurate analysis. Drawing insights from both historical data and future projections, the study highlights the expected growth of the Hyperthermia Treatment for Cancer market…
Hyperthermia Instrument Market Growth Outlook and Future Scope: 2026-2033 | Cels …
The qualitative latest Research report (2026-2033) on the Hyperthermia Instrument Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
➤ Request a Sample Copy (Complete TOC, Tables…
Non-Viral Transfection Reagents Market Revolutionizing Gene Editing and Therapy …
According to a new report published by CoherentMI The non-viral transfection reagents market is estimated to be valued at USD 687 Mn in 2024 and is expected to reach USD 1,200 Mn by 2031, growing at a compound annual growth rate (CAGR) of 8.3% from 2024 to 2031.
The Global Non Viral Transfection Reagents Market has recently been analyzed and explored by CoherentMI in their latest market research report. The team…
North America Liposome Drug Delivery Market Analysis and Experts Review Report 2 …
The report presents an in-depth assessment of the 'North America Liposome Drug Delivery Market'. This includes enabling demand, key trends, market drivers, challenges, competition, standardization, regulatory landscape, deployment models, competitive analysis, operator case studies, opportunities, future trends, value chains, ecosystem player profiles, and strategies included. The report also presents a SWOT analysis and forecast for North America Liposome Drug Delivery investments from 2019 to 2027.
"The North America Liposome Drug Delivery…
Deadline on Dec. 28th coming up in Lawsuit filed for Investors in Celsion Corpor …
A deadline is coming up on December 28, 2020 in the lawsuit filed for certain investors of Celsion Corporation (NASDAQ: CLSN) over alleged securities laws violations by Celsion Corporation.
Investors who purchased shares of Celsion Corporation (NASDAQ: CLSN) have certain options and there are strict and short deadlines running. Deadline: December 28, 2020. NASDAQ: CLSN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Lawsuit filed for Investors in shares of Celsion Corporation (NASDAQ: CLSN)
An investor, who purchased shares of Celsion Corporation (NASDAQ: CLSN), filed a lawsuit over alleged violations of Federal Securities Laws by Celsion Corporation.
Investors who purchased shares of Celsion Corporation (NASDAQ: CLSN) have certain options and for certain investors are short and strict deadlines running. Deadline: December 28, 2020. NASDAQ: CLSN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Lawrenceville, NJ based Celsion Corporation, an integrated…
